Loading ...

ligand-mediated nanoparticles composed of glycyrrhetinic acid-modified poly(ethylene glycol)-poly(β-benzyl-L-asparate

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

glycyrrhetinic acid-modified poly(ethylene glycol)-poly(β-benzyl-L-asparate

GA-PEG-PBLA
Type Polymer
Formula
Role raw materials

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Product

ligand-mediated nanoparticles composed of glycyrrhetinic acid-modified poly(ethylene glycol)-poly(β-benzyl-L-asparate

Size: 70 - 80 nm

Medium/Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • glycyrrhetinic acid-modified poly(ethylene glycol)-poly(β-benzyl-L-asparate
  1. uRs39bRUjHSgFNUrL6YHcvpKAb
Product

ligand-mediated nanoparticles composed of glycyrrhetinic acid-modified poly(ethylene glycol)-poly(β-benzyl-L-asparate

Size: 70.5 - 71.3 nm

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial